Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polymeric anticancer drugs with pH-controlled activation.

Karel Ulbrich1, Vladimír Subr

  • 1Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Sq. 2, 162 06 Prague 6, Czech Republic. ulbrich@imc.cas.cz

Advanced Drug Delivery Reviews
|April 7, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD64-Targeted Polymer-Drug Conjugates Exploit Cathepsin K-Dependent Payload Release for Selective Elimination of Immunosuppressive Macrophages.

Molecular pharmaceutics·2026
Same author

Lopinavir Derivative as Potent P-gp Inhibitor Enables Delivery through HPMA Copolymer Conjugates and Overcoming Tumor Chemoresistance to Conventional Cytostatic Drugs.

Biomacromolecules·2026
Same author

Uncovering the glutamate carboxypeptidase II microenvironment using a multi-labeling proteomic approach.

Scientific reports·2025
Same author

Polymer Nanomedicines with pH-Triggered Pirarubicin Release: Revealing the Role of Carrier Hydrophilicity and Release Kinetics in Anticancer Performance.

Biomacromolecules·2025
Same author

Polymer-Tethered Quenched Fluorescent Probes for Enhanced Imaging of Tumor-Associated Proteases.

ACS sensors·2024
Same author

Polymer-tethered quenched fluorescent probes for enhanced imaging of tumor associated proteases.

bioRxiv : the preprint server for biology·2024

Macromolecular carriers improve anti-cancer drug delivery. Acid-sensitive linkers ensure drug release in tumor tissues, enhancing cancer therapy effectiveness.

Area of Science:

  • Polymer chemistry
  • Drug delivery systems
  • Oncology

Background:

  • Macromolecular carriers offer a promising strategy for anti-cancer drug delivery.
  • Effective therapeutic activity relies on the controlled release of drugs from these carriers.
  • Tumor microenvironments, including acidic extracellular fluids and intracellular compartments, present opportunities for targeted drug release.

Purpose of the Study:

  • To review advancements in acid-sensitive macromolecular drug delivery systems.
  • To explore the properties and development of these innovative carrier systems.
  • To highlight the potential of targeted drug delivery for improved cancer treatment.

Main Methods:

  • Review of literature on polymer-drug conjugates with acid-sensitive linkers.

Related Experiment Videos

  • Analysis of systems ranging from simple conjugates to antibody-targeted constructs.
  • Evaluation of drug release mechanisms in acidic tumor environments and intracellular compartments.

    • Main Results:

    • Acid-sensitive spacers facilitate drug release in tumor tissues.
    • Drug release can be triggered by slightly acidic extracellular pH or intracellular acidic organelles.
    • Development spans from basic polymer-drug conjugates to sophisticated antibody-targeted systems.

    Conclusions:

    • Acid-sensitive macromolecular carriers represent a significant advancement in cancer therapy.
    • These systems enable targeted drug release, potentially increasing efficacy and reducing side effects.
    • Future developments may involve more complex and site-specific targeting strategies.